
Why GLP-1s aren't lowering employers' costs
Employer coverage of GLP-1 weight loss medications like Ozempic and Zepbound is rising, yet the financial logic behind these benefits remains contentious. While one in eight U.S. adults now uses these drugs, only 20% of employer health plans provide coverage, often under the assumption that improved employee health wil...




















